A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome
Clinical trial NCT04447729 · WITHDRAWN
Trial details
- NCT number
- NCT04447729
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2022-02-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.